MedWatch

GN Hearing's top line took a dive in Q1 – firm maintains 2021 guidance

Hearing aid manufacturer GN Hearing expects to grow more than 25 percent organically in 2021. In the first quarter, organic growth was 1 percent, according to interim report on Thursday.

Photo: GN Store Nord / PR

GN Hearing's interim report, published on Thursday, hardly holds any surprises. Three weeks ago, GN hearing had already unveiled a list of figures for the first three months of the year in connection with upgrading its other business leg GN Audio.

As implied then, the interim report on Thursday states that GN Hearing will maintain its guidance for the rest of 2021.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs